JP2023510304A - 肺癌におけるｄｎａ変異の検出のための画像識別多重アッセイ - Google Patents

肺癌におけるｄｎａ変異の検出のための画像識別多重アッセイ Download PDF

Info

Publication number
JP2023510304A
JP2023510304A JP2022542157A JP2022542157A JP2023510304A JP 2023510304 A JP2023510304 A JP 2023510304A JP 2022542157 A JP2022542157 A JP 2022542157A JP 2022542157 A JP2022542157 A JP 2022542157A JP 2023510304 A JP2023510304 A JP 2023510304A
Authority
JP
Japan
Prior art keywords
seq
probe
dna
sequence
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2022542157A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023510304A5 (https=
Inventor
ディーン ツァオ，
チン－ショウ ヒュアン，
シアン ピン フー，
フェイ－ユイ チャン，
イー リン シエ，
Original Assignee
プレックスバイオ カンパニー， リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by プレックスバイオ カンパニー， リミテッド filed Critical プレックスバイオ カンパニー， リミテッド
Publication of JP2023510304A publication Critical patent/JP2023510304A/ja
Publication of JP2023510304A5 publication Critical patent/JP2023510304A5/ja
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2022542157A 2020-01-08 2021-01-07 肺癌におけるｄｎａ変異の検出のための画像識別多重アッセイ Ceased JP2023510304A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062958599P 2020-01-08 2020-01-08
US62/958,599 2020-01-08
PCT/US2021/012541 WO2021142153A1 (en) 2020-01-08 2021-01-07 Image differentiated multiplex assays for detection of dna mutations in lung cancer

Publications (2)

Publication Number Publication Date
JP2023510304A true JP2023510304A (ja) 2023-03-13
JP2023510304A5 JP2023510304A5 (https=) 2024-01-17

Family

ID=76788349

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022542157A Ceased JP2023510304A (ja) 2020-01-08 2021-01-07 肺癌におけるｄｎａ変異の検出のための画像識別多重アッセイ

Country Status (5)

Country Link
US (1) US20230052147A1 (https=)
EP (1) EP4087948A4 (https=)
JP (1) JP2023510304A (https=)
CN (1) CN115210385A (https=)
WO (1) WO2021142153A1 (https=)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014144121A2 (en) * 2013-03-15 2014-09-18 Life Technologies Corporation Classification and actionability indices for lung cancer
CN107881232A (zh) * 2017-10-26 2018-04-06 上海仁东医学检验所有限公司 探针组合物及基于ngs方法检测肺癌和结直肠癌基因的应用
WO2018107183A1 (en) * 2016-12-09 2018-06-14 Plexbio Co., Ltd. Image differentiated multiplex assays for multiplex detection of dna mutations

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014144121A2 (en) * 2013-03-15 2014-09-18 Life Technologies Corporation Classification and actionability indices for lung cancer
WO2018107183A1 (en) * 2016-12-09 2018-06-14 Plexbio Co., Ltd. Image differentiated multiplex assays for multiplex detection of dna mutations
CN107881232A (zh) * 2017-10-26 2018-04-06 上海仁东医学检验所有限公司 探针组合物及基于ngs方法检测肺癌和结直肠癌基因的应用

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
J. MOL. DIAGN., vol. 13, JPN6025010048, 2011, pages 74 - 84, ISSN: 0005697028 *
JAMA, vol. 311, JPN6025010049, 2014, pages 1998 - 2006, ISSN: 0005697029 *
RESPIR. MED., vol. 107, JPN6025010050, 2013, pages 1755 - 1762, ISSN: 0005697030 *
SCI. REP., vol. 9, no. 5207, JPN6025010051, 2019, pages 1 - 13, ISSN: 0005697031 *

Also Published As

Publication number Publication date
EP4087948A4 (en) 2024-05-01
US20230052147A1 (en) 2023-02-16
EP4087948A1 (en) 2022-11-16
WO2021142153A1 (en) 2021-07-15
CN115210385A (zh) 2022-10-18

Similar Documents

Publication Publication Date Title
US12516372B2 (en) Compositions and methods for screening mutations in thyroid cancer
JP5986572B2 (ja) 固定化プライマーを使用した標的ｄｎａの直接的な捕捉、増幅、および配列決定
RU2603074C2 (ru) Способ и продукт для локализованной или пространственной детекции нуклеиновой кислоты в образце ткани
US20150126376A1 (en) Compositions and methods for sensitive mutation detection in nucleic acid molecules
EP3551767B1 (en) Image differentiated multiplex assays for multiplex detection of dna mutations
CA2957633A1 (en) Digital measurements from targeted sequencing
US10894975B2 (en) Image differentiated multiplex assays for multiplex detection of DNA mutations
WO2015183836A1 (en) Compositions, methods, and uses related to ntrk2-tert fusions
JP2023065620A (ja) Ｄｎａ配列のクラスター化のための方法
ES2712941T3 (es) Método para la detección de mutaciones en BRAF y PI3K
JP2023510304A (ja) 肺癌におけるｄｎａ変異の検出のための画像識別多重アッセイ
TW202129008A (zh) 檢測異檸檬酸脫氫酶突變的套組及方法
WO2021041765A2 (en) Kit and methods to detect ntrk gene fusion
WO2021041762A1 (en) Kit and methods to detect egfr variant iii
US9062350B2 (en) Method of mutation detection in blood cell-free DNA using primer extension (PE) and PCR
US20170081713A1 (en) Multivalent probes having single nucleotide resolution
KR20150039540A (ko) 변이관련 뉴클레오타이드가 있는 올리고뉴클레오타이드와 포착프로브를 이용한 뉴클레오타이드 변이 분석 방법 및 장치
BR122020011728B1 (pt) Método para detectar pelo menos uma mutação em uma pluralidade de genes relacionados a câncer de tireoide, para selecionar um sujeito que tem nódulos na tireoide com citologia indeterminada para cirurgia diagnóstica, e para prognosticar risco de malignidade em um sujeito com resultados de citologia para paaf da tireoide inconclusivos, e, kit para detectar pelo menos uma mutação em genes relacionados ao câncer de tireoide em uma amostra ffpe da tireoide ou uma amostra paaf da tireoide, e para detectar pelo menos um produto de fusão genética em uma amostra ffpe da tireoide ou uma amostra paaf da tireoide
BR112018013430B1 (pt) Métodos para detectar pelo menos uma mutação em uma pluralidade de genes relacionados a câncer de tireoide, para selecionar um sujeito que tem nódulos na tireoide, e, para prognosticar risco de malignidade

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240109

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240109

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250318

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250616

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250930

A045 Written measure of dismissal of application [lapsed due to lack of payment]

Free format text: JAPANESE INTERMEDIATE CODE: A045

Effective date: 20260127